Intersection / Topic

study compares glp 1 drugs on their benefits harms medpage today

Rank map, news, and discussion for study compares glp 1 drugs on their benefits harms medpage today. · United States · Snapshot day 2026-07-25

Not in today’s tops Unclear US 0 comments Rank map search

Today’s ranks

Platform Rank Matching item
Google Not in today’s top list
Bing Not in today’s top list
YouTube Not in today’s top list
X Not in today’s top list
Poly Not in today’s top list
TikTok Not in today’s top list
FB Not in today’s top list
IG Not in today’s top list

Open in…

News hits

  1. 1

    Study Compares GLP-1 Drugs on Their Benefits, Harms - MedPage Today

    Google News

  2. 2

    Expanding Early Intensive Treatment Beyond Glycemia in Type 2 Diabetes - MedPage Today

    Google News

  3. 3

    Health Gains Vanish Within 2 Years of Stopping Weight-Loss Drugs - MedPage Today

    Google News

  4. 4

    WIC Telehealth Program Improved Diet, Had Modest Impact on Weight Gain in Pregnancy - MedPage Today

    Google News

  5. 5

    Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor - MedPage Today

    Google News

  6. 6

    Screen Every Adult for Unhealthy Alcohol Use, USPSTF Says - MedPage Today

    Google News

  7. 7

    Bariatric Surgery Linked With Lower Mortality vs GLP-1 Drugs in Study, but ... - MedPage Today

    Google News

  8. 8

    Novel GLP-1/GIP Agent Led to Weight Loss With Once-Monthly Dosing - MedPage Today

    Google News

  9. 9

    Prescription-Free Online Semaglutide Is Risky Business - MedPage Today

    Google News

  10. 10

    Online Sellers of Compounded GLP-1s Often Don't Mention Risks - MedPage Today

    Google News

  11. 11

    A Drink or Two a Day Won't Help Prolong Life - MedPage Today

    Google News

  12. 12

    GLP-1 Agonists for Diabetes Tied to Lower Hyperkalemia Rates - MedPage Today

    Google News

Discussion 0 · optional name or Anonymous

Be kind. No spam. Comments are filtered for safety (guidelines). Held comments are not public until reviewed.

No comments yet — start the thread.
Topic pages combine today’s rank map, free news indexes, and public comments. Lean badges use curated outlet labels — not a fact-check or endorsement. Not affiliated with listed platforms. Be civil — comments are public.